(S)-Perillyl Alcohol Temozolomide

（S）-紫苏醇替莫唑胺

Report date: 2025/08/06 11:45:43
NME

Base Information

Drug Name(S)-Perillyl Alcohol Temozolomide
Drug Alias NameTMZ-POH(s)-perillyl alcohol temozolomide carbamateNEO-212
ClassificationSmall molecules
Mechanisms of ActionDNA synthesis inhibitorsDNA cross linking agentsAlkylating agents
TargetsDNA
Therapy Area/IndicationsBrain metastasesGastroesophageal Junction NeoplasmsSolid tumours +[22] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeonc Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeonc Technologies Inc
Inactive CompaniesN/A
Active IndicationsBrain metastasesGastroesophageal Junction NeoplasmsSolid tumours +[22] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A